Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $79.2600 (0.75%) ($77.3400 - $79.5200) on Mon. May. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.99% (three month average) | RSI | 39 | Latest Price | $79.2600(0.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(50%) VYM(50%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -0.495% in a week (0% probabilities). TLT(-15%) UUP(-13%) VXX(-12%) IFRA(-11%) VIXM(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.495% (StdDev 0.99%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
1 - 5 Day Possible Target | $75.86(-4.29%) | Resistance Level | $79.84 | 5 Day Moving Average | $78.91(0.44%) | 10 Day Moving Average | $79.12(0.18%) | 20 Day Moving Average | $79.84(-0.73%) | To recent high | -5.6% | To recent low | 2.2% | Market Cap | $139.837b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |